Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Renal Pharmacotherapy -

Renal Pharmacotherapy (eBook)

Dosage Adjustment of Medications Eliminated by the Kidneys
eBook Download: PDF
2013 | 2013
XXIII, 752 Seiten
Springer New York (Verlag)
978-1-4614-5800-5 (ISBN)
Systemvoraussetzungen
96,29 inkl. MwSt
(CHF 93,95)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

As the population of patients with acute or chronic kidney disease grows, healthcare professionals need a resource that optimizes drug effectiveness while minimizing potential toxicity.  Renal Pharmacotherapy is a comprehensive listing of dosage recommendations for patients with compromised renal function.  This up-to-date and evidence-based reference closes several identified knowledge gaps concerning medications eliminated by the kidneys.

 

Conveniently listed alphabetically by generic drug name, each drug has its own face page featuring typical dosing ranges, alternative dosing adjustments by strata of renal function, specific dosing for dialysis and other dosing schemes.

 

This work will satisfy the dosing information needs of busy physicians involved in pharmacotherapy for patients with kidney disease, as well as pharmacists, nurses and students.

 



Larry Golightly is the lead author of this book and currently the Clinical Assnt Professor at the University of Colorado Skaggs Schook of Pharmacy and Pharmaceutical Sciences. Dr. Golightly is a thought leader in pharmacy science and has been an invited presentor to domestic and international conferences and committees. The following assisted Dr. Golightly in preparing this book: Isaac Teitelbaum, MD, FACP Tyree H. Kiser, PharmD, BCPS Dimitriy R. Levin, MD Gerard R. Barber, RPh, MPH, FASHP Michael A. Jones, PharmD Nancy M. Stolpman, PharmD, PhD Katherine S. Lundin, PharmD Every author is at the University of Colorado Hospital in Aurora, CO.


As the population of patients with acute or chronic kidney disease grows, healthcare professionals need a resource that optimizes drug effectiveness while minimizing potential toxicity. Renal Pharmacotherapy is a comprehensive listing of dosage recommendations for patients with compromised renal function. This up-to-date and evidence-based reference closes several identified knowledge gaps concerning medications eliminated by the kidneys. Conveniently listed alphabetically by generic drug name, each drug has its own face page featuring typical dosing ranges, alternative dosing adjustments by strata of renal function, specific dosing for dialysis and other dosing schemes. This work will satisfy the dosing information needs of busy physicians involved in pharmacotherapy for patients with kidney disease, as well as pharmacists, nurses and students.

Larry Golightly is the lead author of this book and currently the Clinical Assnt Professor at the University of Colorado Skaggs Schook of Pharmacy and Pharmaceutical Sciences. Dr. Golightly is a thought leader in pharmacy science and has been an invited presentor to domestic and international conferences and committees. The following assisted Dr. Golightly in preparing this book: Isaac Teitelbaum, MD, FACP Tyree H. Kiser, PharmD, BCPS Dimitriy R. Levin, MD Gerard R. Barber, RPh, MPH, FASHP Michael A. Jones, PharmD Nancy M. Stolpman, PharmD, PhD Katherine S. Lundin, PharmD Every author is at the University of Colorado Hospital in Aurora, CO.

 This book is an alphabetical directory of drugs, listed by generic name. Thus, the book will have 26 chapters - one chapter per letter (chapter 1 will have all drugs starting with the letter "A", chapter 2 with drugs starting with letter "B", etc.).​

Erscheint lt. Verlag 28.2.2013
Zusatzinfo XXIII, 752 p. 1 illus.
Verlagsort New York
Sprache englisch
Themenwelt Medizinische Fachgebiete Innere Medizin Nephrologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Schlagworte acute and chronic diseases management, • antibacterial drug resistance • drug directory, • drug elimination, renal insufficiency and impairment, • pharmacotherapy • Renal Pharmacotherapy, dosage adjustment,
ISBN-10 1-4614-5800-5 / 1461458005
ISBN-13 978-1-4614-5800-5 / 9781461458005
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 3,7 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich